Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report, General Medicine
Editorial, Hair Transplant
Letter to the Editor, General Medicine
Letter to the Editor, Trichology
Original Article, Trichology
Review Article, Trichology
Viewpoint, General Medicine
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report, General Medicine
Editorial, Hair Transplant
Letter to the Editor, General Medicine
Letter to the Editor, Trichology
Original Article, Trichology
Review Article, Trichology
Viewpoint, General Medicine
View/Download PDF

Translate this page into:

Original Article
Trichology
1 (
1
); 2-6
doi:
10.25259/JHRRM_15_2025

A comparative, open-label, randomised study; evaluating efficacy of a hand-held device using a combination of vibration and cold, versus only vibration; in reducing the pain sensation of multiple local anaesthesia injections during hair transplant

Department of Hair Restoration, Centro Capilar, Madrid, Spain,
Hi-Tech Clinics, Nagpur, Maharashtra, India,
Department of Hair Restoration, Nonthaburi, Thailand,
Department of Dermatology, Mumbai, Maharashtra, India.

*Corresponding author: Shashank Bansod, Hi Tech Clinics, Nagpur, Maharashtra, India hitech.skin@yahoo.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Seiadatan A, Bansod S, Butwong B, Savant S. A comparative, open labelled, randomised study; evaluating efficacy of a hand-held device using a combination of vibration and cold, versus only vibration; in reducing the pain sensation of multiple local anaesthesia injections during hair transplant. J Hair Restor Regen Med 2026;1:2-6 doi: 10.25259/JHRRM_15_2025

Abstract

Objectives:

The objective of this study is to evaluate the efficacy of a novel single hand-held device that uses a combination of vibration and cold, for reducing the pain sensation due to local anesthesia injections during hair transplant surgery, and compare it with a device using only vibration for the same purpose

Materials and Methods:

The Leniwand vibratory cooling device, having an outer body shell made with surgical-grade stainless steel, is used in the study. The device has principal parts, the hand-held vibrator and the stainless-steel cooling cube, which is filled with coolant solution. A split scalp study on 30 male patients aged 27-51 years, who were to undergo 1%lignocaine injections on the scalp for a hair transplant procedure, was done. The study comprised of using a cooled (providing both cold and vibration) vs non cooled (only vibration) Leni wand device on each half of scalp, 30 seconds before injections, and injecting as close to the device as possible, to compare reduction in pain sensation due to injections on both sides while keeping brand of syringe, operator, depth of injections same.

Results:

In the injected area where Leni wand was used, 17 people experienced substantial pain reduction,7 experienced some pain reduction, five people experienced no difference, and one person claimed pain aggravation.

Limitations:

All the patients in the study were male; this was a selection bias, as most hair transplant procedures in our practice are performed on males.

Conclusion:

Leni wand, which uses both cold and vibration to reduce pain, was found to be more effective for this purpose than using only vibration, with some limitations.

Keywords

Anesthesia
Cold and vibration
Hair transplant
Leni wand
Pain reduction

INTRODUCTION

Pain is a commonly defined limiting factor from a patient's point of view when it comes to common trichology procedures, including platelet-rich plasma therapy and hair transplants, which involve multiple pricks via needle to the scalp. Physicians always try to reduce the extent of this pain felt by patients, using various pharmacological and non-pharmacological measures. Many pharmacological agents, most commonly topical anesthetics including EMLA™, Elamax™, liposome-encapsulated lidocaine cream, amethocaine, cetacaine, and benzocaine products, are being used to reduce the pain of these procedures.[1]

Although local anesthesia is sufficient for many dermatologic procedures, it may still be ineffective for pain reduction in quite a few procedures. Also, administration of local anesthetic creams may cause high discomfort in some patients[2], especially if multiple needle pricks are required for local anesthesia. Much research has been devoted to the development of effective topical anesthetics and to scrutinizing their efficacy in reducing procedure-induced pain.[1,3]

In spite of that, topical anesthetic application does not provide sufficient pain relief practically, is time-consuming, and may cause a variety of complications, such as allergic reactions and toxicities.[4,5]

EMLA™, for example, is associated with extensive corneal de-epithelialization,[6] purpura and petechiae[7-9], and even methemoglobinemia in a few patients if applied to large areas.[10-12]

Quite a few non-pharmacological modalities are also being routinely used for pain reduction, including vibration devices, cold application, hand holding, and talking to distract the patient (so-called talkesthesia); they find much favor with the treating physician. Although talkesthesia for painful procedures is helpful, alone, it often is insufficient.[13]

Patients may opt out of a beneficial treatment just because of the pain element. Hence, any intervention that may reduce pain is always an asset. With this in mind, we decided to evaluate the effectiveness of a novel vibrating and cooling device, Leniwand (manufacturer), versus only vibration in reducing the pain sensation of local anesthesia injections during hair transplant surgery.

The gate control theory by Melzack and Wall helps to understand how non-pharmacological modalities of vibration and cooling may reduce the perception of pain.[14,15]

The application of vibration has long been used for pain reduction, due to neurophysiological effects as well as placebo effects. According to gate control theory, A-β nerve fibers, which transmit information from vibration receptors (Pacinian corpuscles and Meissner corpuscles) and touch receptors in the skin, stimulate inhibitory interneurons in the spinal cord that in turn act to reduce the amount of pain signal transmitted by A-δ and C fibers from the skin to second-order neurons that cross the midline of the spinal cord and then ascend to the brain.[16,17]

Regarding the treatment of pain by vibration, a Lancet editorial concludes that the use of vibration is "simple, safe, and highly effective and has the added advantage of being cheap to establish and maintain, even in dermatological procedures.[18,1]

On the other hand, the use of cold to relieve pain has been employed since Hippocrates in the 4th century BC.[19] Cooling the tissue also induces vasoconstriction, which may decrease swelling and ecchymosis.[20]

Prolonged cold application (30–60 s) can stimulate the C nociceptive fibers and block the A-delta pain transmission signal when applied close to the nociception source.[21]

The stimulation of C fibers by cold application also transmits slow pain and noxious thermal information to the brain in activating a supraspinal modulation, which increases the body’s overall pain threshold and therefore produces a generalized hypoalgesia at the insertion site.[22,23]

MATERIAL AND METHODS

The Leniwand vibratory cooling device used in this study has an outer body shell made with surgical-grade stainless steel. The two principal parts of the device are: the hand-held vibrator and the cuboid stainless steel cooling cube. The cooling cube is filled with a coolant solution. These two separate parts can easily be detached and attached with a simple screw mechanism.

The coolant-filled stainless steel cube is pre-cooled inside the freezer compartment of the refrigerator (-18°C approximately) for a minimum of 2 hours. During the procedure, the cooling device is removed from the freezer and attached to the vibratory part. This assembled device can easily be held in one hand, as seen in [Figure 1]

Leniwand hand-held single device, which uses both cold and vibration together and helps in pain reduction of injectables. It has a front globular part, which is filled with coolant and is removable, and a back vibrating part. The device is made of stainless steel and is easily cleanable.
Figure 1:
Leniwand hand-held single device, which uses both cold and vibration together and helps in pain reduction of injectables. It has a front globular part, which is filled with coolant and is removable, and a back vibrating part. The device is made of stainless steel and is easily cleanable.

A total of 30 male patients aged 27 to 51 years undergoing 1% lignocaine local anesthesia injections for frontal to mid-scalp hair implantation surgery were included in the study. Allergies to lignocaine or other components of local anesthesia, local site infection, systemic illness, and patients with chronic pain conditions or taking painkiller medications were excluded.

The device was switched on, kept in contact with the skin surface for 30 seconds prior to injection of local anesthetic, with the needle tip insertion point being as close to the cold vibrating part of the device as possible. The anesthesia on one side, starting centrally at the forehead midpoint on the frontal scalp and moving laterally to the temporal area, was administered along with the precooled Leniwand cold vibrating device. On the contralateral side, the same process was repeated with the same non-cooled Leniwand vibrating at the same rotations per minute, but at room temperature. For standardization, the same operator holds the Leniwand vibratory cooling device in the nondominant hand and injects with the dominant hand in all patients in the study. All local anesthesia injections with 1 % lignocaine using 31 G insulin syringes of the same brand (Benet Dickinson). Only one syringe per side and changed to a fresh syringe when changing sides; again, done for standardization. The side to be injected using the Leniwand vibratory cooling device, and only vibration was randomly selected. Using the same Leniwand vibrating devices with the same material and dimensions (one side cooled vs the other side at room temperature) on either side again helped further reduce variance. An eleven-point numeric rating scale NRS (0-10) was used to determine the pain score on either side. The NRS is an 11-point scale on which “0” indicates no pain and “10” indicates the worst pain imaginable [Figure 2]. It was selected because it is both accurate and easy to use. For general purposes, the numeric rating scale has good sensitivity and generates data that can be statistically analyzed for audit purposes.[24]

11-point NRS pain scale from 0-10, where 0 indicates no pain, and 10 indicates the worst pain imaginable. NRS is a widely used, straightforward method to assess the pain levels experienced by patients, clinically, quickly. NRS: numeric rating scale
Figure 2:
11-point NRS pain scale from 0-10, where 0 indicates no pain, and 10 indicates the worst pain imaginable. NRS is a widely used, straightforward method to assess the pain levels experienced by patients, clinically, quickly. NRS: numeric rating scale

As this was a split scalp study, a verbal response scale was designed where the patients were verbally asked as a direct comparison which side felt less painful; with responses being noticeably less pain, slightly less pain, no difference, slightly more pain, and noticeably more pain. The control and study sites were assigned within the same patient to rule out bias from individual variations in pain perception, and the study was open-label since it was not possible to blind the patients due to the nature of the device being tested.

RESULTS

In this split scalp study, the following results were observed. Seventeen patients reported a noticeable reduction in pain sensation on the vibratory cooling device side; a further 7 reported a slight reduction in pain on the vibratory cooling side; 5 reported almost no perceptible difference on either side; and one patient reported more pain on the vibratory cooling side. The results are shown in Figure 3 below:

Patients where both cooling and vibration was used (blue bars) experienced less pain as compared to patients where only vibration was used (red bars).
Figure 3:
Patients where both cooling and vibration was used (blue bars) experienced less pain as compared to patients where only vibration was used (red bars).

Statistical analysis

Results of the paired-t test indicated that there is a significantly large difference between Vibration score (M = 5, SD = 1.1) and Vibration & cooling score (M = 3.6, SD = 1.2), t(29) = 7.3, p < .001. Indicating that the vibration and cooling device has provided better pain relief compared to only vibration in this study.

DISCUSSION

Pain is a significant surgical problem; 75% of surgical patients experience pain before, during, or after procedures.[25]

Cooling and vibration are effective in reducing the pain sensation. A number of studies provide evidence that cooling alone or vibration used standalone is effective in reducing the pain sensation of injection.[26-29]

In this study, the Leniwand vibratory cooling device was found to reduce the pain sensation significantly more compared to vibration alone for local anesthesia injections in hair transplant surgery.

The Leni wand device with a surgical-grade stainless steel body can be easily and quickly disinfected. Such properties in a device may be of particular benefit for a wider acceptance in healthcare.[30-34]

Studies indicate that the application of cold before and after injection helps reduce pain, erythema, and swelling.[35,36] Also, cold application reduces the chances of developing ecchymosis and helps in faster resolution of ecchymosis.[37]

Cooling the treatment area with a firm pressure application with Leni wand post-injection or at the end of the procedure may help reduce the pain, inflammation, erythema, or swelling that can develop post-procedure (PRP injections, Botulinum Toxin, fillers, and laser or energy therapies) on the face, where such a cooling effect is desired. Leniwand device is versatile, can be used only in cooling mode or vibration only mode, or combination mode as desired.

Maximizing patient comfort is an important consideration for all procedures, especially elective aesthetic procedures. Anticipated injection pain has been shown to be a factor in delaying BTX-A treatments for naïve and repeat patients.[38] A survey of cosmetic patients revealed that concerns about procedure discomfort rated third in importance to surgical result and physician communication.[39]

Leniwand vibratory cooling device has been used by authors in regular practice during intra-lesional therapy, PRP injections on the face and scalp. There have been no long-term side effects. Some patients do complain of cold and numbness immediately post-procedure, but this is a temporary phenomenon. Also, a few patients find the vibration feeling and noise annoying or unpleasant, but this may be beneficial as a distraction mechanism for reducing the pain sensation.

Combining vibration and cooling, Leniwand's vibratory cooling device is an easy-to-use, single-handed, inexpensive, and fast-acting solution for reducing procedural pain.

Due to its non-pharmacological action, it has no major side effects. Its quick assembly prior to the procedure doesn't require much time. All this increases acceptance of the device for the treating physician.

It helps reduce the fear of the needle and pain in the patient's mind, which is a major hindrance for patients opting out of cosmetic or office procedures.

LIMITATIONS

All the patients in the study were male; this was a selection bias, as most hair transplant procedures in our practice are performed on males.

CONCLUSION

The Leniwand vibratory cooling device has the potential to provide better pain relief for injections compared to just plain vibratory devices. The limitations of the study were that all participants were male patients, the sample size was small, and it was open-label, so some bias is possible. Larger multi-center trials with blinded assessors can be taken up to validate these findings.

This device provides a non-invasive, fast, reusable, easy-to-use solution for injection pain and has a wide variety of potential clinical and health care indications, including all types of injections, office cosmetic procedures, vaccinations, and self-injectors like those used by people with diabetes for insulin.

Author contributions:

AS: Contributed towards study conception and design, data analysis, statistical analysis, and definition of intellectual content; SB and BB: Contributed to the study concepts, definition of intellectual content, literature search, clinical studies, and perfomed data analysis; SS: Contributed towards study conception, definition of intellectual content, literature search, is responsible for data acquisition, and performed statistical analysis.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient's consent not required as patients identity is not disclosed or compromised.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil

References

  1. , , , , . Vibration anesthesia: A noninvasive method of reducing discomfort prior to dermatologic procedures. Dermatol Online J. 2004;10:1.
    [CrossRef] [PubMed] [Google Scholar]
  2. , . Topical Anesthetics for cosmetic and laser dermatology. J Drugs Dermatol. 2005;4:455-61.
    [Google Scholar]
  3. , . Topical Anesthetics in dermatology. J Am Acad Dermatol. 2000;43:286-98.
    [CrossRef] [PubMed] [Google Scholar]
  4. , . Percutaneous penetration of local anesthetic bases: Pharmacodynamic measurements. J Invest Dermatol. 1999;113:304-7.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , , . Comparative study of the efficacy of four topical anesthetics. Dermatol Surg. 1999;25:950-4.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , . EMLA Cream-induced eye injury. Arch Dermatol. 1999;135:855-6.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , . EMLA Cream: An improved local anesthetic. Review of current literature. Pediatr Dermatol. 1992;9:126-31.
    [CrossRef] [PubMed] [Google Scholar]
  8. , . Purpura caused by EMLA is of toxic origin. Contact Dermatitis. 1997;36:11-3.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , . Petechial eruption after the application of EMLA cream. Pediatrics. 1998;101:471-3.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , , . Inverse relationship between age-dependent erythrocyte activity of methaemoglobin reductase and prilocaine-induced methaemoglobinaemia during infancy. Br J Anaesth. 1990;64:72-6.
    [CrossRef] [PubMed] [Google Scholar]
  11. , . Toxic methaemoglobin concentrations in premature infants after application of a prilocaine-containing cream and peridural prilocaine. Eur J Pediatr. 1999;158:785-8.
    [CrossRef] [PubMed] [Google Scholar]
  12. , . Signs of methaemoglobinaemia after topical application of EMLA cream in an infant with haemangioma. Dermatology. 1997;195:153-4.
    [CrossRef] [PubMed] [Google Scholar]
  13. , . Pediatric anesthesia in dermatologic surgery: When hand-holding is not enough. Dermatol Surg. 2001;27:1010-8.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , . Gate control theory of pain In: Encyclopedia of Behavioral Medicine. Cham: Springer; . p. :914-6.
    [CrossRef] [Google Scholar]
  15. , , . Academic pain medicine: A practical guide to rotations, fellowship, and beyond. Cham: Springer; 2019:1-386.
    [CrossRef] [Google Scholar]
  16. , . Pain mechanisms: A new theory. Science. 1965;150:971-9.
    [CrossRef] [PubMed] [Google Scholar]
  17. . From the gate to the neuromatrix. Pain. 1999;S6:S121-6.
    [CrossRef] [PubMed] [Google Scholar]
  18. Vibration Therapy for pain. Lancet. 1992;339:1513-4.
    [CrossRef] [Google Scholar]
  19. . Wilderness Medicine: Physical methods for treatment of pain (5th ed). St Louis: Mosby; .
    [Google Scholar]
  20. , , , . Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane) Plast Reconstr Surg. 2006;117:3S-4S.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , . An integration of vibration and cold relieves venipuncture pain in a pediatric emergency department. Pediatr Emerg Care. 2011;27:1151-6.
    [CrossRef] [PubMed] [Google Scholar]
  22. , . Innocuous skin cooling modulates perception and neurophysiological correlates of brief CO2 laser stimuli in humans. Eur J Pain. 2005;9:521-30.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , . An integration of vibration and cold relieves venipuncture pain in a pediatric emergency department. . 2011;27:1151-6.
    [CrossRef] [PubMed] [Google Scholar]
  24. , . Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798-804.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , . Postoperative pain experience: Results from a national survey. Anesth Analg. 2003;97:534-40.
    [CrossRef] [PubMed] [Google Scholar]
  26. , . Effect of topical vapocoolant spray on skin test wheel, flare, and pain responses. Ann Allergy Asthma Immunol. 2005;95:149-53.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , . Skin cooling for botulinum toxin A injection in focal axillary hyperhidrosis. Ann Plast Surg. 2007;58:299-302.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , . Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections. Aesthet Surg J. 2011;31:966-71.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , . Vibration anesthesia for the reduction of pain with facial dermal filler injections. Aesthetic Plast Surg. 2014;38:413-8.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , . Antimicrobial activity of copper surfaces against Salmonella enterica and Campylobacter jejuni. BMC Microbiol. 2004;4:19.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , . Potential use of copper surfaces to reduce MRSA survival. J Hosp Infect. 2006;63:289-97.
    [CrossRef] [PubMed] [Google Scholar]
  32. , , . The survival of Escherichia coli O157 on metal surfaces. Int J Food Microbiol. 2005;105:445-54.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , . Survival of Listeria monocytogenes Scott A on metal surfaces: Implications for cross-contamination. Int J Food Microbiol. 2006;111:93-8.
    [CrossRef] [PubMed] [Google Scholar]
  34. , , . Metallic copper as an antimicrobial surface. Appl Environ Microbiol. 2011;77:1541-7.
    [CrossRef] [PubMed] [Google Scholar]
  35. , , . The use of a contact cooling device to reduce pain and ecchymosis with dermal filler injections. J Clin Aesthet Dermatol. 2010;3:29-34.
    [Google Scholar]
  36. , . Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg. 2007;120:98S-105S.
    [CrossRef] [PubMed] [Google Scholar]
  37. , . Assessment of four methods in subcutaneous heparin applications regarding bruise and pain. Int J Nurs Pract. 2013;19:402-8.
    [CrossRef] [PubMed] [Google Scholar]
  38. , . Reduction of pain and anxiety prior to botulinum toxin injections with a new topical anesthetic method. Ophthal Plast Reconstr Surg. 2009;25:173-7.
    [CrossRef] [PubMed] [Google Scholar]
  39. . Evaluation Of cosmetic oculoplastic surgery patient In: Cosmetic Oculoplastic Surgery (3rd edition). Philadelphia: WB Saunders; . p. :77-90.
    [Google Scholar]
Show Sections